Fish or pills? study tests best way to boost young hearts

NCT ID NCT06729229

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study looks at whether eating two portions of fish per week or taking omega-3 supplements can improve blood vessel health and raise omega-3 levels in young adults aged 18 to 30. Participants with low omega-3 levels and little fish intake will be assigned to one of four groups: fish plus placebo, fish plus omega-3 supplement, omega-3 supplement alone, or placebo alone. The goal is to see if these simple changes can help prevent future heart disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

fish and omega-3 supplements

What this could lead to

If effective, this could show that simple dietary changes or supplements help young adults reach heart-healthy omega-3 levels, potentially reducing future cardiovascular risk.

What could go wrong

This is a small, early-stage study with 40 participants, so results may not apply to everyone. It tests short-term effects, not long-term disease prevention.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Locations

  • NICHE, School of Biomedical Sciences, Biomedical Sciences Research Institute, Coleraine Campus, University of Ulster

    Coleraine, Co Londonderry, BT52 1SA, United Kingdom